Overview

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To determine whether the combination of MM-121 plus paclitaxel is more effective than paclitaxel alone
Phase:
Phase 2
Details
Lead Sponsor:
Merrimack Pharmaceuticals
Collaborator:
Sanofi
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel